Fipamezole hydrochloride 90 mg oral disintegrating tablets

( DrugBank: Fipamezole / KEGG DRUG: - )

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
6	パーキンソン病	2

告示番号	疾患名（ページ内リンク）	臨床試験数
17	多系統萎縮症	2

6. パーキンソン病

臨床試験数 : 2,307 / 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

trials per page:

Showing 1 to 2 of 2 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2007-004890-24-PT (EUCTR)	07/10/2008	25/06/2008	A Phase II, Randomised, Placebo-Controlled, Double-Blind, Replicated Crossover, Pilot Study on the E ...	A Phase II, Randomised, Placebo-Controlled, Double-Blind, Replicated Crossover, Pilot Study on the E ...	Neurogenic orthostatic hypotension in patients with multiple system atrophy or Parkinson's disease M ...	Product Name: Fipamezole hydrochloride 90 mg oral disintegrating tablets Product Code: JP-1730/F01 INN ...	Juvantia Pharma Ltd	NULL	Not Recruiting			Female: yes Male: yes	24	Phase 2	Portugal;France
2	EUCTR2007-004890-24-FR (EUCTR)	07/05/2008	09/05/2008	A Phase II, Randomised, Placebo-Controlled, Double-Blind, Replicated Crossover, Pilot Study on the E ...	A Phase II, Randomised, Placebo-Controlled, Double-Blind, Replicated Crossover, Pilot Study on the E ...	Neurogenic orthostatic hypotension in patients with multiple system atrophy or Parkinson's disease M ...	Product Name: Fipamezole hydrochloride 90 mg oral disintegrating tablets Product Code: JP-1730/F01 INN ...	Juvantia Pharma Ltd	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	24	Phase 2	Portugal;France

臨床試験数 : 119 / 薬物数 : 138 - (DrugBank : 44) / 標的遺伝子数 : 59 - 標的パスウェイ数 : 111

trials per page:

Showing 1 to 2 of 2 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2007-004890-24-PT (EUCTR)	07/10/2008	25/06/2008	A Phase II, Randomised, Placebo-Controlled, Double-Blind, Replicated Crossover, Pilot Study on the E ...	A Phase II, Randomised, Placebo-Controlled, Double-Blind, Replicated Crossover, Pilot Study on the E ...	Neurogenic orthostatic hypotension in patients with multiple system atrophy or Parkinson's disease M ...	Product Name: Fipamezole hydrochloride 90 mg oral disintegrating tablets Product Code: JP-1730/F01 INN ...	Juvantia Pharma Ltd	NULL	Not Recruiting			Female: yes Male: yes	24	Phase 2	Portugal;France
2	EUCTR2007-004890-24-FR (EUCTR)	07/05/2008	09/05/2008	A Phase II, Randomised, Placebo-Controlled, Double-Blind, Replicated Crossover, Pilot Study on the E ...	A Phase II, Randomised, Placebo-Controlled, Double-Blind, Replicated Crossover, Pilot Study on the E ...	Neurogenic orthostatic hypotension in patients with multiple system atrophy or Parkinson's disease M ...	Product Name: Fipamezole hydrochloride 90 mg oral disintegrating tablets Product Code: JP-1730/F01 INN ...	Juvantia Pharma Ltd	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	24	Phase 2	Portugal;France